Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | -1.05% | 87.30 | 1.3% | $1275.26m | |
| AMGN | Amgen Inc. | -0.25% | 198.89 | 1.2% | $667.61m | |
| GILD | Gilead Sciences, Inc. | -1.28% | 67.64 | 0.9% | $577.79m | |
| BIIB | Biogen Inc. | -1.63% | 332.03 | 1.3% | $485.41m | |
| LOXO | Loxo Oncology Inc | -0.18% | 233.26 | 12.7% | $449.60m | |
| ILMN | Illumina, Inc. | 0.05% | 305.63 | 3.5% | $350.96m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.28% | 186.15 | 1.9% | $318.23m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.12% | 404.54 | 2.6% | $308.69m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.03% | 111.70 | 2.0% | $229.47m | |
| TSRO | TESARO, Inc. | 0.03% | 74.88 | 14.4% | $201.67m | |
| A | Agilent Technologies, Inc. | -0.82% | 70.02 | 1.5% | $164.25m | |
| EXAS | Exact Sciences Corporation | -2.75% | 74.97 | 25.3% | $151.07m | |
| INCY | Incyte Corporation | -2.79% | 76.56 | 2.5% | $146.84m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.45% | 119.26 | 15.4% | $142.24m | |
| LGND | Ligand Pharmaceuticals Incorporated | -16.48% | 110.05 | 23.1% | $105.44m |
Company Profile
Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop innovative, targeted medicines for cancer and other proliferative diseases. The company builds a diversified biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products includes CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.